Russell Investments Group’s iShares US Healthcare ETF IYH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$186K Sell
2,779
-471
-14% -$29.5K ﹤0.01% 3207
2026
Q1
$200K Sell
3,250
-15
-0.5% -$969 ﹤0.01% 2851
2025
Q4
$213K Sell
3,265
-976
-23% -$61.6K ﹤0.01% 2827
2025
Q3
$249K Buy
4,241
+2,805
+195% +$160K ﹤0.01% 2729
2025
Q2
$81.1K Buy
1,436
+2
+0.1% +$113 ﹤0.01% 2873
2025
Q1
$87.3K Buy
1,434
+943
+192% +$57.6K ﹤0.01% 2786
2024
Q4
$28.6K Buy
491
+2
+0.4% +$124 ﹤0.01% 2947
2024
Q3
$31.8K Sell
489
-173
-26% -$11.1K ﹤0.01% 2867
2024
Q2
$40.5K Sell
662
-467
-41% -$28.1K ﹤0.01% 2808
2024
Q1
$69.9K Sell
1,129
-66
-6% -$3.97K ﹤0.01% 2612
2023
Q4
$68.5K Sell
1,195
-810
-40% -$44.1K ﹤0.01% 2606
2023
Q3
$108K Buy
+2,005
New +$112K ﹤0.01% 2604

Other funds holding IYH

Russell Investments Group's IYH Position: Q2 2026 in Review

Russell Investments Group reduced its iShares US Healthcare ETF (IYH) stake by 14% in Q2 2026, selling an estimated $29.5K and leaving 2,779 shares worth $186K. The position accounts for ﹤0.01% of the portfolio, ranked #3207.

Russell Investments Group first reported a position in IYH in Q3 2023 and has held it in 12 quarters since. The position peaked at $249K in Q3 2025. 383 funds tracked by Wall St. Rank hold IYH as of Q2 2026.

  • Russell Investments Group held 2,779 shares of iShares US Healthcare ETF worth $186K as of Q2 2026.
  • Russell Investments Group sold 471 iShares US Healthcare ETF shares in Q2 2026, an estimated $29.5K.
  • iShares US Healthcare ETF made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3207 holding.
  • Russell Investments Group first reported a position in iShares US Healthcare ETF in Q3 2023 and has held it in 12 quarters since.
  • Russell Investments Group's iShares US Healthcare ETF position peaked at $249K in Q3 2025.
  • 383 funds tracked by Wall St. Rank held iShares US Healthcare ETF as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.